Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.
about
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaTreatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsCeftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combinationStructural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumanniiCrystal Structure of Carbapenemase OXA-58 from Acinetobacter baumanniiCarbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the PuzzleBacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infectionAntimicrobial resistance in hospital-acquired gram-negative bacterial infections.Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing?Hospital epidemiology and infection control in acute-care settings.Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010.Surveillance on secular trends of incidence and mortality for device-associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000-2008: a retrospective observational study.Screening for Acinetobacter baumannii colonization by use of sponges.A bronchofiberoscopy-associated outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit in Beijing, China.Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study.Pseudomonas aeruginosa: resistance to the maxIn vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumanniiAntibiotic susceptibility pattern of Enterobacteriaceae and non-fermenter Gram-negative clinical isolates of microbial resource orchid.Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D β-Lactamases.Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure.Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy.A new metric of antibiotic class resistance in gram-negative bacilli isolated from hospitalized children.Microbiological profile of organisms causing bloodstream infection in critically ill patientsInhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisAcinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Influence of clinical breakpoint changes from CLSI 2009 to EUCAST 2011 antimicrobial susceptibility testing guidelines on multidrug resistance rates of Gram-negative rodsMultidrug-resistant bacterial isolates in infected wounds at Jimma University Specialized Hospital, Ethiopia.(99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agentsAntimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities.Drug-resistant ventilator associated pneumonia in a tertiary care hospital in Saudi Arabia.Surveillance and management of multidrug-resistant microorganisms.Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more.
P2860
Q24601746-3559E088-777D-40BF-AE38-18A118FCE5E0Q26991886-E78F5533-89F4-4505-8FEF-E4EDEE56D80AQ26998883-6B7D3A94-F079-433D-8CFE-5E10CA2487BBQ27679881-CF7403AF-5DE9-483B-9E9E-E707227ACF85Q27681472-F72F54C2-FCB2-45E8-B383-AB2CEA2F5F10Q28078925-D19A5315-1E32-42E6-AE51-6F1495A6FCE2Q28365026-C6818319-9698-472B-864D-ECBCB9B4862BQ28478751-5B4CF6DD-7BD2-49D4-8A36-1A1AAF7B9893Q30300006-E9883C8B-78D5-4D37-BB99-7606BC8E3941Q30416893-3B24CF8B-B417-4C99-AD32-42ACD30705F5Q30429049-6F1BC1F6-FFD1-423C-8C91-49D359A1273DQ30580647-6DB2657F-035E-4C25-BCE0-9022E78331EEQ34296375-7782B032-2388-4FCB-BBD2-CD06DD9D0494Q34410123-43DB4745-B90C-4EC5-8DF1-865E0489F1FDQ34487407-96EAE688-4EA1-4249-9F08-FE72CDA32E2BQ34496802-5034A602-082F-4617-9031-4A154553AECFQ34697193-DB3CFFE6-0E28-4C18-9571-F3C60C5250A1Q35084559-B2B6EC61-E61A-4DFA-8356-DA79C715294DQ35169078-361D934F-5826-40EE-BBA0-2397D08D1634Q35198786-24A458D1-668B-4D0F-A495-FC26BBB93A2BQ35235590-91E81C1A-9BF8-445C-8B86-E1F6446A0F2BQ35530666-4B36890D-9B74-4299-927E-9947FD72B0D5Q35987600-BD61F7E9-45E9-4429-91D8-E55772A02D2FQ36035185-57038678-3FE9-4C6B-A7E8-07F5AF712F36Q36106267-77997786-06FA-4654-8128-A8EAF5BA9EFCQ36220803-3BA33EE1-FB82-4075-97C9-339D48A799B1Q36435455-52650218-3CD0-4B94-AB8D-DFF3E006154DQ36442068-C9FC836B-EF83-406A-8F8C-3A53E5B09443Q36457770-2E0F4BEE-FFA1-4CA6-AA25-A0D1ABDFD824Q36569183-48024557-4DF8-4B97-9141-C5AF2A83F47AQ36910650-352B6696-5D52-4182-B222-C3A1C4130A96Q36971280-4884D429-55C5-4E2A-BBA8-D32E15B70172Q37048219-0ED67007-6898-46B3-A9FA-9124B87C6764Q37304150-A2FCB30F-C500-4323-A069-54AD7B1BD6FFQ37544784-4D5550FC-6853-4E81-B6B2-318148D47AC7Q37733295-0F8288E2-7B8E-4B54-B209-656BC3DACD18Q37912231-A462240E-3B89-4B7E-8D41-F93ACB27D54AQ37949391-E80C7AAF-1680-441A-92C8-BB28A759924DQ37993716-06F75F3C-9C08-4299-B7AF-6CF96A0CC7A7Q38267242-E26C5F29-BF5C-4C9F-BDFD-E455970C3316
P2860
Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@ast
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@en
type
label
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@ast
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@en
prefLabel
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@ast
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@en
P2093
P356
P1476
Multidrug resistance among gra ...... are Safety Network, 2006-2008.
@en
P2093
Alexander J Kallen
Alicia I Hidron
Arjun Srinivasan
Jean Patel
P304
P356
10.1086/652152
P577
2010-05-01T00:00:00Z